Within the framework of the PoCOsteo Horizon 2020 project, BBMRI.at partner Biobank Graz started collecting osteoporosis samples earlier this year. The project aims at developing point-of-care in-vitro devices to measure and/or quantify proteomic and genomic factors in human whole blood.
The clinical cohort includes male and female patients aged fifty years and older and ranges from healthy (per definition) to those who experienced multiple fragility fractures due to secondary osteoporosis.
It comprises untreated patients as well as those treated for osteoporosis, with or without concomitant diseases such as hypertension, diabetes etc.
Read more about the cohort on the BBMRI.at website.